Acute Side Effects in Patients Who Are Undergoing Stereotactic Radiosurgery for Brain Tumors or Other Brain Disorders

Sponsor
Case Comprehensive Cancer Center (Other)
Overall Status
Completed
CT.gov ID
NCT00255671
Collaborator
(none)
76
1
84
0.9

Study Details

Study Description

Brief Summary

RATIONALE: Learning about the side effects of stereotactic radiosurgery in patients with brain tumors or other brain disorders may help doctors plan treatment and help patients live more comfortably.

PURPOSE: This clinical trial is studying the acute side effects in patients who are undergoing stereotactic radiosurgery for brain tumors or other brain disorders.

Condition or Disease Intervention/Treatment Phase
  • Other: Questionnaire

Detailed Description

OBJECTIVES:
  • Determine the incidence and types of acute complications in patients undergoing stereotactic radiosurgery for brain tumors or other brain disorders.

  • Determine the time frame for development and resolution of these complications in these patients.

  • Determine the severity of these complications in these patients.

OUTLINE: Patients undergo stereotactic radiosurgery. Patients also complete questionnaires about the side effects they experience from radiosurgery. The questionnaires are completed at baseline and at 1 week, 1 month, and 2 months after radiosurgery.

PROJECTED ACCRUAL: A total of 94 patients will be accrued for this study.

Study Design

Study Type:
Observational
Actual Enrollment :
76 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
Prospective Study on the Short-Term Adverse Effects From Gamma Knife Radiosurgery
Study Start Date :
May 1, 2005
Actual Primary Completion Date :
Apr 1, 2008
Actual Study Completion Date :
May 1, 2012

Outcome Measures

Primary Outcome Measures

  1. Short-term adverse effects as assessed by a questionnaire [at 1 week, 1 month, and 2 months]

    Patients undergo stereotactic radiosurgery. Patients also complete questionnaires about the side effects they experience from radiosurgery. The questionnaires are completed at baseline and at 1 week, 1 month, and 2 months after radiosurgery.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
DISEASE CHARACTERISTICS:
  • Diagnosis of brain tumor or other brain disorder, including, but not limited to, 1 of the following:

  • Primary brain tumors

  • Brain metastases

  • Acoustic neuromas

  • Pituitary adenomas

  • Parkinson's disease

  • Cluster headaches

  • Glomus jugulare

  • Epilepsy

  • Obsessive compulsive disorder

  • Arteriovenous malformations

  • Trigeminal neuralgia

  • Eligible for and scheduled to undergo stereotactic radiosurgery

PATIENT CHARACTERISTICS:

Performance status

  • Not specified

Life expectancy

  • Not specified

Hematopoietic

  • Not specified

Hepatic

  • Not specified

Renal

  • Not specified

Other

  • No physical or mental limitation that would preclude study compliance
PRIOR CONCURRENT THERAPY:

Endocrine therapy

  • Concurrent steroids allowed

Radiotherapy

  • No prior stereotactic radiosurgery

Contacts and Locations

Locations

Site City State Country Postal Code
1 Cleveland Clinic Taussig Cancer Center Cleveland Ohio United States 44195

Sponsors and Collaborators

  • Case Comprehensive Cancer Center

Investigators

  • Principal Investigator: John Suh, MD, Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Case Comprehensive Cancer Center
ClinicalTrials.gov Identifier:
NCT00255671
Other Study ID Numbers:
  • CASE4Z05
First Posted:
Nov 21, 2005
Last Update Posted:
Jul 27, 2020
Last Verified:
Jul 1, 2020

Study Results

No Results Posted as of Jul 27, 2020